{
    "nctId": "NCT01884337",
    "officialTitle": "A Phase IV, Open-Label, Multi-center Study to Evaluate the Safety of Apixaban in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery",
    "inclusionCriteria": "* Age \u226518 years\n* Subjects undergoing elective total knee or hip replacement or a revision of at least one component of a total knee or hip replacement\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Women who are pregnant or breastfeeding\n* Known or suspected, acquired or bleeding or coagulation disorder in the subject or a first degree relative\n* Active bleeding or at high risk for bleeding.\n* Brain, spinal, ophthalmologic, or major surgery or trauma within the past 90 days other than the elective knee/hip surgery\n* Active hepatobiliary disease\n* Hemoglobin \\<9 g/dL\n* Platelet count \\<100,000/mm3\n* Creatinine clearance \\<30 mL/min"
}